Figure 5From: Stereotactic body radiotherapy for localized prostate cancer: disease control and quality of life at 6 yearsMedian PSA at baseline and after SBRT for both dose groups and for patients treated with or without hormones (=/- standard deviation). Dose did not significantly alter PSA levels over time.Back to article page